Recombinant human PD1 protein (Fc Chimera Active)
- Bioactive
- 각 태그의 뜻
Be the first to review this product! Submit a review
|
(1 Publication)
Recombinant human PD1 protein (Fc Chimera Active) is a Human Fragment protein, in the 25 to 167 aa range, expressed in HEK 293 cells, with >95%, < 0.1 EU/g endotoxin level, suitable for SDS-PAGE, FuncS, HPLC.
대체 명칭 보기
CD279, PD1, PDCD1, Programmed cell death protein 1, Protein PD-1, hPD-1
- FuncS
Supplier Data
Functional Studies - Recombinant human PD1 protein (Fc Chimera Active) (AB221398)
Loaded Human PD-1, Fc Tag, low endotoxin (HPLC-verified) on Protein A Biosensor, can bind Human PD-L1, His Tag (HPLC & BLI verified) with an affinity constant of 5.3μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
- FuncS
Unknown
Functional Studies - Recombinant human PD1 protein (Fc Chimera Active) (AB221398)
Immobilized Biotinylated Human PD-L2, Avitag,His Tag (recommended for biopanning) at 1 µg/mL (100 µL/well) on streptavidin precoated (0.2 µg/well) plate, can bind Human PD-1, Fc Tag, low endotoxin (HPLC-verified) with a linear range of 0.1-1 ng/mL.
- FuncS
Unknown
Functional Studies - Recombinant human PD1 protein (Fc Chimera Active) (AB221398)
Immobilized Human PD-1, Fc Tag, low endotoxin (HPLC-verified) at 2 µg/mL (100 µL/well) can bind Biotinylated Human PD-L2, Fc,Avitag with a linear range of 0.5-16 ng/mL.
- FuncS
Unknown
Functional Studies - Recombinant human PD1 protein (Fc Chimera Active) (AB221398)
The purity of Human PD-1, Fc Tag, low endotoxin (HPLC-verified) was greater than 90% as determined by SEC-HPLC.
- FuncS
Unknown
Functional Studies - Recombinant human PD1 protein (Fc Chimera Active) (AB221398)
Flow Cytometry assay shows that Human PD-1, Fc Tag, low endotoxin (HPLC-verified) can bind to 293 cell overexpressing human PD-L1. The concentration of PD-1 used is 1 μg/mL.
- FuncS
Unknown
Functional Studies - Recombinant human PD1 protein (Fc Chimera Active) (AB221398)
Immobilized Biotinylated Human PD-L1, Avitag,His Tag (recommended for biopanning) at 1 μg/mL (100 μL/well) on streptavidin precoated (0.5 μg/well) plate, can bind Human PD-1, Fc Tag, low endotoxin with a linear range of 0.1-3 ng/mL (QC tested).
- FuncS
Unknown
Functional Studies - Recombinant human PD1 protein (Fc Chimera Active) (AB221398)
Human PD-1, Fc Tag, low endotoxin (HPLC-verified) captured on CM5 chip via anti-human IgG Fc antibody, can bind Human PD-L1, His Tag (HPLC-verified) with an affinity constant of 3.6 μM as determined in a SPR assay (Biacore T200).
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant human PD1 protein (Fc Chimera Active) (AB221398)
SDS-PAGE using ab221398 under reducing (R) condition. The gel was stained overnight with Coomassie Blue.
Reactivity 정보
제품 세부 정보
서열 정보
특성 및 보관 정보
제형
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PD1 serves as an inhibitory receptor acting as a checkpoint in the immune system. It becomes part of an immune-suppressive complex when it binds with its ligands PD-L1 or PD-L2 which are expressed on various cell types including some tumor cells. This interaction suppresses the proliferation of T cells and cytokine production contributing to immune homeostasis. By controlling T cell activity PD1 limits autoimmunity but can also reduce the immune system's capability to attack cancer cells.
Pathways
PD1 functions in the immune checkpoint pathway a critical regulatory circuit in immune regulation. The engagement of PD1 with its ligands initiates a cascade that inhibits the function and proliferation of T cells through downstream SHP-2 phosphatase activity. This pathway frequently involves other regulatory proteins like CTLA-4 and is an important mechanism by which the body modulates immune responses. Related pathways often intersect with those involving T cell receptor signaling and contribute to the overall modulation of immune activity.
일반 정보
기능
Inhibitory receptor on antigen activated T-cells that plays a critical role in induction and maintenance of immune tolerance to self (PubMed : 21276005, PubMed : 31754127, PubMed : 32184441, PubMed : 37208329). Delivers inhibitory signals upon binding to ligands CD274/PDCD1L1 and CD273/PDCD1LG2 (PubMed : 21276005, PubMed : 26602187). Following T-cell receptor (TCR) engagement, PDCD1 associates with TCR-CD3 in the immunological synapse and directly inhibits T-cell activation (PubMed : 32184441). Suppresses T-cell activation through the recruitment of PTPN11/SHP-2 : following ligand-binding, PDCD1 is phosphorylated within the ITSM motif, leading to the recruitment of the protein tyrosine phosphatase PTPN11/SHP-2 that mediates dephosphorylation of key TCR proximal signaling molecules, such as ZAP70, PRKCQ/PKCtheta and CD247/CD3zeta (PubMed : 32184441).. The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival (PubMed : 28951311). The interaction with CD274/PDCD1L1 inhibits cytotoxic T lymphocytes (CTLs) effector function (PubMed : 28951311). The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy (PubMed : 22658127, PubMed : 25034862, PubMed : 25399552).
Post-translational modifications
Ubiquitinated at Lys-233 by the SCF(FBXO38) complex, leading to its proteasomal degradation (PubMed:30487606). Ubiquitinated via 'Lys-48'-linked polyubiquitin chains (PubMed:30487606). Deubiquitinated and thus stabilized by USP5 (PubMed:37208329).. Tyrosine phosphorylated at Tyr-223 (within ITIM motif) and Tyr-248 (ITSM motif) upon ligand binding (PubMed:31754127, PubMed:32184441). Phosphorylation at Tyr-248 by FYN promotes the recruitment of the protein tyrosine phosphatase PTPN11/SHP-2 that mediates dephosphorylation of key TCR proximal signaling molecules, such as ZAP70, PRKCQ/PKCtheta and CD247/CD3zeta (PubMed:32184441). Phosphorylation at Thr-234 promotes the recruitment of the deubiquitinase USP5 (PubMed:37208329).. N-glycosylation at Asn-58 contains at least two N-acetylglucosamine units and one fucose (PubMed:28165004). N-glycosylation does not affect binding to nivolumab drug (PubMed:28165004).
타겟 정보
제품이 사용된 논문 (1)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Journal of the National Cancer Institute 115:1392-1403 PubMed37389416
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com